Annual Meeting 2019


AHPPI Annual Meeting

Friday 11 October, 09.00 – 17.00

Kings Place, Kings Cross, London

We are pleased to present the programme for this year’s AHPPI Annual Meeting.


Impending change, innovations and future challenges

09:00 Arrival and Coffee  
09:15 Welcome and opening remarks Dr Tim Hardman, Chairman, AHPPI
  Morning Session Chaired by Professor Emma Baker, Clinical Vice President, British Pharmacological Society
09.30 Phase I trials in patients with cancer. A vision of 2020 and beyond Professor Duncan Jodrell, Cancer Therapeutics at University of Cambridge

Monoclonal antibodies: Predicting the next chapter

Dr Phil Barrington, Transcript Partners
10:50 Tea/Coffee & Networking  
11:20 The challenge of novel trial designs on clinical trial application approval Dr Kirsty Wydenbach, MHRA
12:00 Oxford Debate: The value of placebo subjects in Phase I studies
Motion: “We no longer need to include placebo subjects.”
For the motion: Dr Sven van Dijkman, GSK, NL
Against the motion: Dr Peter Dewland, MAC
13:00 Lunch and networking  
  Afternoon Session Chaired by Dr Jim Bush, Covance
14:00 Keynote speech, How real change happens Dr Stephen Carver, Honorary Fellow of The Institute of Risk Management and an Honorary Fellow of the Association of Project Management
14:55 The biopharmcaeutical impact of the delivery of both large and small molecular drugs via non-oral routes of administration Dr Eddie French, Formulation Consultant, TEKH Consulting Ltd
15:25 Tea/Coffee & Networking  
15:55 Simulation and the in-silico environment in Phase I Marco Siccardi, University of Liverpool
16:35 The Data Driven Transformation In Drug Development Dr Satnam Surae, Chief Product Officer, Aigenpulse
17:10 Discussion and closing remarks Dr Tim Hardman, Chairman, AHPPI

The meeting will be followed by a reception.

Register Now

Members of AHPPI qualify for discounted rates – join here.

Members of AFPT (ClubPhase 1), AGAH and BAPU qualify for AHPPI member rates.

CPD points for this meeting have been applied for.

Please contact us with any questions at

We are open for sponsorship for this year’s meeting.


Comments are closed.